|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Sucampo Pharmaceuticals, Inc. Announces One-to-One Conversion of Class B Common Stock into Class a Common Stock
8/30/2012 9:35:27 AM
BETHESDA, Md.--(BUSINESS WIRE)--Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) (“Sucampo”) today announced that its majority shareholder and only holder of its class B common stock, S&R Technology Holdings, LLC (S&R), has converted all of its shares of Sucampo’s class B common stock into shares of its class A common stock. S&R is owned by Ryuji Ueno, M.D., Ph.D., Ph.D., Sucampo’s Chairman and CEO, and his wife, Sachiko Kuno, Ph.D., Sucampo’s Executive Advisor, International Business Development and a member of Sucampo’s Board of Directors. Drs. Ueno and Kuno are the co-founders of Sucampo.
|
|
|
|
|
|
|
|
|
|
|